Chronic Disease Management Market
Chronic Disease Management Market Forecasts to 2030 - Global Analysis By Type (Solutions, Services and Other Types), Disease Type (Cardiovascular Diseases, Diabetes, Cancer, Asthma, Chronic Obstructive Pulmonary Disorders and Other Disease Types), End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $6.3 BN |
|
Projected Year Value (2030) |
US $15.6 BN |
|
CAGR (2023 - 2030) |
13.8% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Chronic Disease Management Market is accounted for $6.3 billion in 2023 and is expected to reach $15.6 billion by 2030 growing at a CAGR of 13.8% during the forecast period. The Chronic Disease Management Market is the healthcare sector dedicated to addressing long-term, non-communicable health conditions such as diabetes, heart disease, and cancer. It involves a range of strategies and technologies aimed at preventing, monitoring, and treating these conditions to improve patients' quality of life. Its uses include remote patient monitoring, personalized treatment plans, and data-driven interventions.
According to NCBI, chronic diseases account for about 60% of deaths and 43% of the global disease burden.
Market Dynamics:
Driver:
Increasing of aging population
As demographics shift towards an older populace, there is a heightened prevalence of chronic diseases, as many of these conditions become more common with age. This demographic trend places a substantial burden on healthcare systems and resources, necessitating enhanced disease management strategies. The demand for specialized care, preventive measures, and long-term support for chronic illnesses is on the rise, fostering the development of tailored healthcare solutions and technologies. Addressing the healthcare needs of the aging population not only improves their quality of life but also drives the growth of the chronic disease management market as it becomes increasingly essential in providing effective and efficient care.
Restraint:
Implementations of advanced programs are expensive
Developing and deploying cutting-edge technologies, remote monitoring systems, and personalized treatment solutions often require substantial financial investments. Healthcare organizations and providers may be constrained by budget limitations and face challenges in allocating resources for the adoption of expensive technologies. Additionally, these costs can translate to higher expenses for patients, limiting their access to advanced chronic disease management. The financial burden may also deter smaller healthcare facilities and underserved regions from offering comprehensive disease management services, potentially exacerbating health disparities. Mitigating these cost barriers is essential to ensure equitable access to effective chronic disease management solutions.
Opportunity:
Government healthcare policies and incentives
Many governments worldwide are recognizing the economic and public health implications of rising chronic disease burdens. As a result, they are implementing policies that encourage the development and adoption of innovative disease management solutions. Incentives may include financial support, reimbursement programs, and regulatory frameworks that promote the integration of technology and telehealth into healthcare systems, making it easier for providers to offer effective chronic disease management services. These policies not only stimulate market growth but also contribute to better access to care, reduced healthcare costs, and improved patient outcomes, creating a win-win scenario for healthcare stakeholders and patients alike.
Threat:
Stringent regulations and compliance requirements
While regulations are essential for ensuring patient safety and data security, an overly complex and restrictive regulatory environment can impede innovation and hinder the rapid development and deployment of new technologies and solutions for managing chronic diseases. Compliance challenges can increase the time and cost of bringing products to market, creating barriers for businesses and healthcare providers. Additionally, navigating a complex regulatory landscape may deter some companies from entering the market, limiting competition and potentially limiting the availability of advanced chronic disease management solutions, ultimately impacting patient care and healthcare system efficiency.
Covid-19 Impact:
The COVID-19 pandemic has had a profound impact on the Chronic Disease Management Market. With healthcare systems focused on responding to the pandemic, there has been a disruption in routine chronic disease care. Telemedicine and remote monitoring solutions gained prominence to minimize in-person visits and reduce exposure risks for vulnerable populations. However, the diversion of resources towards pandemic-related efforts and delays in routine screenings and treatments has led to a potential increase in unmanaged chronic conditions, which may have long-term health implications. The pandemic has accelerated the adoption of digital health solutions while highlighting the need for resilient and adaptable chronic disease management strategies.
The services segment is expected to be the largest during the forecast period
The services segment is expected to have lucrative growth in the market. Services in the market encompass a wide range of healthcare offerings tailored to address the needs of individuals dealing with long-term health conditions. These services include disease prevention and education, diagnostic testing, treatment planning, medication management, and lifestyle counseling. Healthcare providers offer patient-centered care by leveraging technology for remote monitoring, telehealth consultations, and data-driven interventions to track and manage chronic diseases effectively. Support groups and mental health services also play a vital role in addressing the emotional and psychological aspects of living with a chronic condition.
The diabetes segment is expected to have the highest CAGR during the forecast period
The diabetes segment is anticipated to witness the fastest CAGR growth during the forecast period. Diabetes is a central focus in the chronic disease, given its widespread prevalence and the need for comprehensive management. This chronic condition, characterized by high blood sugar levels, requires ongoing monitoring, lifestyle adjustments, and often medication or insulin therapy. Healthcare providers and digital health solutions offer a range of services, including glucose monitoring devices, diabetic education programs, personalized dietary and exercise plans, and telehealth consultations. The goal is to empower individuals with diabetes to better manage their condition, reduce the risk of complications, and improve their overall quality of life.
Region with largest share:
During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. The region encompasses the United States and Canada, where the aging population, lifestyle-related diseases, and the rising burden of chronic illnesses drive the demand for innovative disease management solutions. The adoption of telehealth, wearable devices, and electronic health records is widespread, enabling remote monitoring and personalized care. Additionally, government policies and healthcare regulations in North America often encourage the development and implementation of chronic disease management programs, making it a fertile ground for healthcare innovation, with a focus on improving patient outcomes and reducing the economic impact of chronic diseases.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period. The region's significant population, rising middle class and lifestyle changes have led to an increasing prevalence of chronic diseases like diabetes, cardiovascular conditions, and respiratory disorders. Healthcare providers and technology companies are actively introducing innovative solutions for disease prevention, monitoring, and treatment. Telehealth services, mobile health apps, and remote monitoring devices are gaining traction, especially in countries like China and India. Government initiatives to improve healthcare access and the growing awareness among patients about the importance of managing chronic conditions contribute to the market's expansion.
Key players in the market
Some of the key players in Chronic Disease Management market include HealthSmart Holdings, Inc., Vivify Health, Inc, Medecision, Inc., Pegasystems Inc., Allscripts Healthcare Solutions, Inc., Altruista Health, AxisPoint Health, Epic Corporation Inc., TriZetto Corporation, EXL Healthcare, ZeOmega Inc. and Health Catalyst.
Key Developments:
In January 2023, MedStar Health and Zephyr AI, Inc. a start-up specializing in precision medicine technology announced their partnership to work to improve outcomes for chronic diseases, beginning with type 2 diabetes (T2D).
In October 2022, Enli Health Intelligence, a supplier of digital solutions for population health management, was acquired by Cedar Gate Technologies. With the addition of cohort, population, and patient management technologies, risk & quality indicators, gaps in care identification, and patient outreach opportunities, Cedar Gate's enterprise value-based care platform was intended to be expanded for improved outcomes and long-term financial viability.
Types Covered:
• Solutions
• Services
• Other Types
Disease Types Covered:
• Cardiovascular Diseases
• Diabetes
• Cancer
• Asthma
• Chronic Obstructive Pulmonary Disorders
• Other Disease Types
End Users Covered:
• Healthcare Providers
• Healthcare Payers
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Chronic Disease Management Market, By Type
5.1 Introduction
5.2 Solutions
5.2.1 On-Premise Solution
5.2.2 Cloud-Based Solution
5.2.3 Web-Based
5.3 Services
5.3.1 Consulting Services
5.3.2 Implementation Services
5.3.3 Educational Services
5.4 Other Types
6 Global Chronic Disease Management Market, By Disease Type
6.1 Introduction
6.2 Cardiovascular Diseases
6.3 Diabetes
6.4 Cancer
6.5 Asthma
6.6 Chronic Obstructive Pulmonary Disorders
6.7 Other Disease Types
7 Global Chronic Disease Management Market, By End User
7.1 Introduction
7.2 Healthcare Providers
7.3 Healthcare Payers
7.4 Other End Users
8 Global Chronic Disease Management Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 HealthSmart Holdings, Inc.
10.2 Vivify Health, Inc
10.3 Medecision, Inc.
10.4 Pegasystems Inc.
10.5 Allscripts Healthcare Solutions, Inc.
10.6 Altruista Health
10.7 AxisPoint Health
10.8 Epic Corporation Inc.
10.9 TriZetto Corporation
10.10 EXL Healthcare
10.11 ZeOmega Inc.
10.12 Health Catalyst
List of Tables
1 Global Chronic Disease Management Market Outlook, By Region (2021-2030) ($MN)
2 Global Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
3 Global Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
4 Global Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
5 Global Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
6 Global Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
7 Global Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
8 Global Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
9 Global Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
10 Global Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
11 Global Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
12 Global Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
13 Global Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
14 Global Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
15 Global Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
16 Global Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
17 Global Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
18 Global Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
19 Global Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
20 Global Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
21 Global Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
22 Global Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
23 North America Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
24 North America Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
25 North America Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
26 North America Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
27 North America Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
28 North America Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
29 North America Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
30 North America Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
31 North America Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
32 North America Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
33 North America Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
34 North America Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
35 North America Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
36 North America Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
37 North America Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
38 North America Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
39 North America Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
40 North America Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
41 North America Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
42 North America Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
43 North America Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
44 North America Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
45 Europe Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
46 Europe Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
47 Europe Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
48 Europe Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
49 Europe Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
50 Europe Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
51 Europe Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
52 Europe Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
53 Europe Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
54 Europe Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
55 Europe Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
56 Europe Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
57 Europe Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
58 Europe Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
59 Europe Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
60 Europe Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
61 Europe Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
62 Europe Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
63 Europe Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
64 Europe Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
65 Europe Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
66 Europe Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
67 Asia Pacific Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
68 Asia Pacific Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
69 Asia Pacific Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
70 Asia Pacific Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
71 Asia Pacific Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
72 Asia Pacific Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
73 Asia Pacific Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
74 Asia Pacific Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
75 Asia Pacific Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
76 Asia Pacific Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
77 Asia Pacific Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
78 Asia Pacific Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
79 Asia Pacific Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
80 Asia Pacific Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
81 Asia Pacific Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
82 Asia Pacific Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
83 Asia Pacific Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
84 Asia Pacific Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
85 Asia Pacific Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
86 Asia Pacific Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
87 Asia Pacific Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
88 Asia Pacific Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
89 South America Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
90 South America Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
91 South America Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
92 South America Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
93 South America Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
94 South America Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
95 South America Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
96 South America Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
97 South America Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
98 South America Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
99 South America Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
100 South America Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
101 South America Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
102 South America Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
103 South America Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
104 South America Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
105 South America Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
106 South America Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
107 South America Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
108 South America Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
112 South America Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
113 South America Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
114 Middle East & Africa Chronic Disease Management Market Outlook, By Country (2021-2030) ($MN)
115 Middle East & Africa Chronic Disease Management Market Outlook, By Type (2021-2030) ($MN)
116 Middle East & Africa Chronic Disease Management Market Outlook, By Solutions (2021-2030) ($MN)
117 Middle East & Africa Chronic Disease Management Market Outlook, By On-Premise Solution (2021-2030) ($MN)
118 Middle East & Africa Chronic Disease Management Market Outlook, By Cloud-Based Solution (2021-2030) ($MN)
119 Middle East & Africa Chronic Disease Management Market Outlook, By Web-Based (2021-2030) ($MN)
120 Middle East & Africa Chronic Disease Management Market Outlook, By Services (2021-2030) ($MN)
121 Middle East & Africa Chronic Disease Management Market Outlook, By Consulting Services (2021-2030) ($MN)
122 Middle East & Africa Chronic Disease Management Market Outlook, By Implementation Services (2021-2030) ($MN)
123 Middle East & Africa Chronic Disease Management Market Outlook, By Educational Services (2021-2030) ($MN)
124 Middle East & Africa Chronic Disease Management Market Outlook, By Other Types (2021-2030) ($MN)
125 Middle East & Africa Chronic Disease Management Market Outlook, By Disease Type (2021-2030) ($MN)
126 Middle East & Africa Chronic Disease Management Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
127 Middle East & Africa Chronic Disease Management Market Outlook, By Diabetes (2021-2030) ($MN)
128 Middle East & Africa Chronic Disease Management Market Outlook, By Cancer (2021-2030) ($MN)
129 Middle East & Africa Chronic Disease Management Market Outlook, By Asthma (2021-2030) ($MN)
130 Middle East & Africa Chronic Disease Management Market Outlook, By Chronic Obstructive Pulmonary Disorders (2021-2030) ($MN)
131 Middle East & Africa Chronic Disease Management Market Outlook, By Other Disease Types (2021-2030) ($MN)
132 Middle East & Africa Chronic Disease Management Market Outlook, By End User (2021-2030) ($MN)
133 Middle East & Africa Chronic Disease Management Market Outlook, By Healthcare Providers (2021-2030) ($MN)
134 Middle East & Africa Chronic Disease Management Market Outlook, By Healthcare Payers (2021-2030) ($MN)
135 Middle East & Africa Chronic Disease Management Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
